By JENNIFER PITTMAN
Posted June 21, 2002
Silicon Valley / San Jose Business Journal
Only 15 years ago there was almost no effective treatment against multiple sclerosis, the most common neurological disease of young to middle-age adults.
Studies of mysterious and debilitating attacks on the immune system were rare. Research offered little hope to the one to two million people who were affected when the patchy covering around their nerve cells led to muscle spasms, weakness, sensory deficits and visual disturbances. (MORE)